The EU seeks comments on the supplementary regulation banning the use of certain antimicrobials in animals or products of animal origin exported to the EU from third countries
On 6 December 2022, the European Commission published a draft authorisation regulation -Ares (2022) 8453372 for comments on supplementary regulation (EU) 2019/6, the Regulation of the European Parliament and of the Council on the Prohibition of the use of certain antimicrobials in animals or products of animal origin exported to the EU from third countries, The feedback period is from December 6, 2022 to January 3, 2023. The main supplementary elements include: (1) The regulation sets out detailed rules prohibiting the use of antimicrobial products intended to promote growth and increase production in animals or products of animal origin exported to the EU from third countries, as well as antimicrobial agents for the treatment of certain human infections; (2) This regulation applies to live food animals whose combined naming codes (" CN codes ") are specified in Chapter 1, Part 2 of Annex I to Regulation (EEC) No2658/87; It also applies to products of animal origin intended for human consumption for which the CN code is specified in Chapters 2 to 5, 15 and 16 of Part II of Annex I and which fall under sections 3501, 3502 and 3504. It does not apply to gelatin and raw materials referred to in point 1, chapter I, section 14, of Annex III of the European Parliament and of the Council of Regulation (EC) No853/2004; (EC) Collagen and its raw materials as described in Point 1, Chapter 1, Section 15 of Annex III No853/2004; (EC) Highly refined products referred to in point 1 of Chapter I, Section 16 of Annex III No853/2004; Wild animals and their derivatives; Insects, frogs, snails and reptiles, including products derived therefrom; Composite products; Animals or animal products not intended for human consumption, unless the destination of the animal or product has not been decided at the time of accession to the EU; Animals or products of animal origin intended for human consumption are used only in transit in the EU and are not placed on the market; Products of animal origin intended for human consumption, samples for product analysis and quality testing, which are not placed on the market; (3) Restrictions on the use of certain antimicrobials in animals entering the EU or in products derived therefrom. Animals and products exported to the EU from third countries must not be used or originate from animals that have been used with any of the following medicines: antimicrobial products used to promote growth or increase production; Antimicrobial products containing antimicrobial agents included in the list of antimicrobial agents prescribed in Implementing Regulation (EU) NO2020/1255 for the treatment of certain human infections; (4) The list of approved third countries, compliance certificates, dizziness requirements, etc.; (5) Entry into force and application The regulation shall enter into force on the twentieth day after its publication in the Official Journal of the European Union. The conditions for the consignment of animals or products into the EU set out in the authorisation Act shall apply 24 months from the date of operation of the implementing Act referred to in Article 6 (1). The regulation should be fully binding and directly applicable to the Member States.
2026-08-24
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Syngenta Bee Pesticide Protest Shows the Pressure Building Around Crop Protection Giants
-
FDA’s Review of BHT and ADA Signals a New Era for Food Additive Compliance
-
FDA Fast-Tracks U.S. Drug Manufacturing
-
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate
-
FDA Warning Letters Put GMP Back in Focus
-
G20 Pushes Fertilizer Access as Food-Security Risk Rises
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
GM Crop Area Reaches 216 Million Hectares
-
GM Crop Area Reaches 216 Million Hectares
-
Syngenta Caught in Trade Crossfire
Recommend Reading
-
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
-
FDA Delays Beetroot Red and Spirulina Color Orders
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
India Prepares New Seed and Pesticide Laws
-
FDA Pushes New Approach to “No Artificial Colors” Claims
-
Supply and Demand Pressures Combine, PVC Prices Surge and Then Retreat This Week
-
Supply Excess, Acrylonitrile Market Weakens in China
-
Premium Global Chemical Sourcing Requests (2 - 6 Mar, 2026)
-
Aluminum Oxide (Al2O3): Abrasive Uses, Ceramic Applications, and Safety
-
Sodium Nitrate: Fertilizer, Food Curing, and Explosive History
- Hot Searches
- di ammonium phosphate price
- baking soda sds
- pre-gelatinized starch
- 30 mg tirzepatide peptide for sale
- scopolamine powder for sale
- stanozolol sale
- carbon tetrabromide
- pvc resin price news
- 10mg tirzepatide peptide
- retatrutide vendor
- food grade phosphoric acid
- sodium lauryl sulfate suppliers